ANROVSCDT• 6 Months (Normalized)
ANRO vs CDT (Alto Neuroscience Inc. vs CDT Equity Inc.)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $27.5
+22.06%
Alto Neuroscience Inc.
Normalized Baseline0.00%
CDT Performance $0.14
-99.66%
CDT Equity Inc.
Normalized Baseline0.00%
Alpha Spread Margin ANRO LEADS
+121.72 pts
ANRO outperforming by 121.72 percentage points
ANROCDT
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO CDT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(119 dates)
| Date | ANRO Price | ANRO Gain (%) | CDT Price | CDT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $27.50 | +22.06% | $0.14 | -99.66% | +121.72% |
| Sep 22, 2026 | $30.78 | +36.62% | $0.14 | -99.64% | +136.26% |
| Sep 21, 2026 | $30.63 | +35.95% | $0.15 | -99.61% | +135.56% |
| Sep 18, 2026 | $30.27 | +34.35% | $0.17 | -99.56% | +133.91% |
| Sep 17, 2026 | $30.98 | +37.51% | $0.19 | -99.52% | +137.03% |
| Sep 16, 2026 | $30.00 | +33.16% | $0.20 | -99.50% | +132.66% |
| Sep 15, 2026 | $30.25 | +34.27% | $0.20 | -99.49% | +133.76% |
| Sep 14, 2026 | $31.68 | +40.61% | $0.22 | -99.45% | +140.06% |
| Sep 11, 2026 | $32.00 | +42.03% | $0.25 | -99.37% | +141.40% |
| Sep 10, 2026 | $31.68 | +40.61% | $0.35 | -99.13% | +139.74% |
| Sep 09, 2026 | $34.07 | +51.22% | $0.60 | -98.48% | +149.70% |
| Sep 08, 2026 | $35.81 | +58.94% | $0.62 | -98.44% | +157.38% |
| Sep 04, 2026 | $35.55 | +57.79% | $0.63 | -98.42% | +156.21% |
| Sep 03, 2026 | $36.40 | +61.56% | $0.75 | -98.10% | +159.66% |
| Sep 02, 2026 | $36.64 | +62.63% | $0.91 | -97.70% | +160.33% |
Page 1 of 8